American Healthcare REIT (NYSE:AHR) Posts Earnings Results, Misses Estimates By $0.35 EPS

American Healthcare REIT (NYSE:AHR) released its quarterly earnings data on Tuesday. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.35), Zacks reports. The company had revenue of $523.81 million for the quarter, compared to the consensus estimate of $474.26 million. American Healthcare REIT had a negative return on equity of 1.96% and a negative net margin of 1.84%. The firm’s revenue for the quarter was up 12.8% compared to the same quarter last year. American Healthcare REIT updated its FY24 guidance to $1.40-1.43 EPS and its FY 2024 guidance to 1.400-1.430 EPS.

American Healthcare REIT Stock Down 1.5 %

Shares of AHR stock traded down $0.41 during trading hours on Thursday, reaching $26.39. 746,055 shares of the company’s stock were exchanged, compared to its average volume of 1,451,028. American Healthcare REIT has a 1 year low of $12.63 and a 1 year high of $27.77. The stock’s fifty day moving average price is $25.16 and its two-hundred day moving average price is $19.21. The company has a current ratio of 0.29, a quick ratio of 0.29 and a debt-to-equity ratio of 0.60. The stock has a market cap of $3.47 billion and a PE ratio of -55.84.

American Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 18th. Shareholders of record on Friday, September 20th were given a dividend of $0.25 per share. The ex-dividend date was Friday, September 20th. This represents a $1.00 annualized dividend and a yield of 3.79%. American Healthcare REIT’s dividend payout ratio (DPR) is presently -208.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Truist Financial upped their price target on American Healthcare REIT from $22.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Colliers Securities raised shares of American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research note on Sunday, October 13th. Morgan Stanley increased their price target on American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a report on Thursday, August 22nd. Bank of America increased their target price on shares of American Healthcare REIT from $27.00 to $31.00 and gave the stock a “buy” rating in a research note on Tuesday, September 24th. Finally, KeyCorp increased their price target on American Healthcare REIT from $16.00 to $27.00 and gave the stock an “overweight” rating in a report on Monday, September 16th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $23.00.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.